A simplified method for stem cell autografting in multiple myeloma: A single institution experience

Bone Marrow Transplantation

Volumn 44, Issue 11, 2009, Pages 715-719

  Lopez Otero A ^a   Ruiz Delgado, G J ^a,b   Ruiz Arguelles G J ^a,b  

^a CENTRO DE HEMATOLOGÍA Y MEDICINA INTERNA DE PUEBLA   (Mexico)

^b Laboratorios Clinicos de Puebla   (Mexico)

Author keywords

Autografts; Multiple myeloma; Simplified method

Indexed keywords

BORTEZOMIB; CIPROFLOXACIN; CISPLATIN; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; FLUCONAZOLE; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; ONDANSETRON; PREDNISONE; THALIDOMIDE; VINCRISTINE;

ADULT; AGED; APHERESIS; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER MORTALITY; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; GRANULOCYTE; HEALTH CARE COST; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; MALE; MULTIPLE MYELOMA; OUTPATIENT CARE; PRIORITY JOURNAL; PROGNOSIS; SINGLE DRUG DOSE; STEM CELL MOBILIZATION;

ADULT; AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; HUMANS; MALE; MELPHALAN; MIDDLE AGED; MULTIPLE MYELOMA; PROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION; SURVIVAL RATE; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 75049083861     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2009.71     Document Type: Article

References (20)

1. Caers Jo, Vandebroek I, De Raeve H, Michaux L, Trullemans F, Schots R et al. Multiple myeloma. An update on diagnosis and treatment. Eur J Haematol 2008; 81: 329-343.
2. Kyle RA, Gertz MA, Witzig TE, Lust JA, Lacy MQ, Dispenzieri A et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc 2003; 78: 21-33.
3. Ruiz-Delgado GJ, Ruiz-Argüelles GJ. Genetic predisposition for monoclonal gammopathy of undetermined significance. Mayo Clin Proc 2008; 83: 601-603.
4. Ruiz-Argüelles GJ, Gómez-Rangel D, Ruiz-Delgado GJ, Aguilar-Romero L. Multiple myeloma in México: a single institution, twenty-year experience. Arch Med Res 2004; 35: 163-167.
5. Alexanian R, Dimopoulos M. The treatment of multiple myeloma. N Engl J Med 1994; 330: 484-489.
6. Vela-Ojeda J, García-Ruiz-Esparza MA, Padilla-Gonzá lez Y, Gó mez-Almaguer D, Gutiérrez-Aguirre CH, Gó mez-Rangel D et al. Autologous peripheral blood stem cell transplantation in multiple myeloma using oral versus IV melphalan. Ann Hematol 2007; 86: 277-282.
7. Kessinger A, Armitage JO, Landmark JD, Smith DM, Weisenburger DD. Autologous peripheral hematopoietic stem cell transplantation restores hemopoietic function following marrow ablative therapy. Blood 1988; 71: 723-727.
8. Ruiz-Argüelles A. Flow cytometry in the clinical laboratory. Principles, applications and problems. Ann Biol Clin 1992; 50: 735-743.
9. Greipp PR, San Miguel J, Durie BG, Crowley JJ, Barlogie B, Bladé J et al. International staging system for multiple myeloma. J Clin Oncol 2005; 23: 3412-3420.
10. Ruiz-Argüelles GJ, Gómez-Rangel D, Ruiz-Delgado GJ, Ruiz-Argüelles A, Pérez-Romano B, Rivadeneyra L. Results of an autologous non-cryopreserved, unmanipulated peripheral blood hematopoietic stem cell transplant program: a single institution, 10-year experience. Acta Haematol 2003; 110: 179-183.
11. Ruiz-Argüelles GJ. Amoebic paralytic ileus in a patient given an autologous stem cell transplantation. Haema 2006; 9: 431-432.
12. Mehta J, Singhal S. Current status of autologous hematopoietic stem cell transplantation in myeloma. Bone Marrow Transplant 2008; 42(Suppl 1): S28-S34.
13. López-Otero A, Ruiz-Delgado GJ, Ruiz-Argüelles GJ. Es cierto que el trasplante de médula ó sea autó loga mejora el pronó stico de los pacientes con mieloma mú ltiple?: Experiencia de una sola institución en México. Medicina Universitaria 2008; 10: 187-189.
14. Gertz MA, Ansell SM, Dingli D, Dispenzieri A, Buadi FK, Elliott MA et al. Autologous stem cell transplant in 716 patients with multiple myeloma: low treatment-related mortality, feasibility of outpatient transplant, and effect of a multidisciplinary quality initiative. Mayo Clin Proc 2008; 83: 1131-1138.
15. Ruiz-Argüelles GJ, Ruiz-Argüelles A, Pérez-Romano B, Marín-López A, Delgado-Lamas JL. Non-cryopreserved peripheral blood stem cells autotransplants for hematological malignancies can be performed entirely on an outpatient basis. Am J Hematol 1998; 58: 161-164.
16. Ruiz-Argüelles GJ. Outpatient programs of myeloablative chemotherapy, autologous and allogeneic bone marrow transplantation. Haematologica 2000; 85: 1233-1234.
17. Gó mez-Almaguer D. The simplification of the SCT procedures in developing countries has resulted in cost-lowering and availability to more patients. Int J Hematol 2002; 76(Suppl 1): 380-382.
18. Ruiz-Argüelles GJ, Ruiz-Argüelles A, Pérez-Romano B, Marín-López A, Larregina-Díez A, Apreza-Molina MG. Filgrastim-mobilized peripheral-blood stem cells can be stored at 4 degrees and used in autografts to rescue high-dose chemotherapy. Am J Hematol 1995; 48: 100-103.
19. Thomas ED. Hematopoietic stem cell transplantation. Sci Am 1995; 272: 38-47.
20. Gajewski JL, Robinson P. Do affluent societies have the only option for the best therapy? Leukemia 2007; 21: 387-388.